Compare
Amgen vs Vertex Pharmaceuticals
Amgen (AMGN) and Vertex Pharmaceuticals (VRTX) side by side, from official filings: what insiders, members of Congress and funds reported. These are counts of what was filed, not a view on either stock.
| Amgen AMGNNASDAQ · Biotechnology | Vertex Pharmaceuticals VRTXNASDAQ · Biotechnology | |
|---|---|---|
| Insider records, last 12 months | 146 | 218 |
| Congress trades, last 12 months | 17 | 5 |
| Fund positions reported, last 12 months | 259 | 184 |
| Federal contract awards, last 12 months | 0 | 0 |
| Open-market purchases by insiders since 2006 | 9 | 52 |
| Open-market sales by insiders since 2006 | 512 | 3,755 |
| Last open-market purchase by an insider | Aug 19, 2015 | Aug 7, 2025 |
| Next results | Nov 3, 2026 | Nov 2, 2026 |
Counts of records OQRO holds, by their date. Insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned and automatic sales are included in the sales.
Common questions
Which has had more insider buying, Amgen or Vertex Pharmaceuticals?
Since 2006, Vertex Pharmaceuticals insiders reported 52 open-market purchases against 9 for Amgen, in SEC Forms 4 and 5. Counts depend on the number of insiders and how long each company has been listed.
Do members of Congress trade AMGN or VRTX?
In the last 12 months, members of Congress disclosed 17 trades in Amgen (AMGN) and 5 in Vertex Pharmaceuticals (VRTX), each reported as a value range on a periodic transaction report.
When did insiders last buy AMGN and VRTX?
Amgen: Aug 19, 2015. Vertex Pharmaceuticals: Aug 7, 2025. Dates are those of the SEC filings.
See the record behind any of these
Each company page opens free with one real filing and the counts of the last 12 months. OQRO Pro adds the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Amgen pageVertex Pharmaceuticals pageRare insider trades this weekAll comparisons
https://oqro.io/compare/amgn-vs-vrtx